Inactief instrument

Koers IMV Inc. Toronto S.E.

Aandelen

Duur

Periode

Stijl

Transcript : IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023	16-03-23
Transcript : IMV Inc., Q3 2022 Earnings Call, Nov 11, 2022	11-11-22
Transcript : IMV Inc., Q2 2022 Earnings Call, Aug 11, 2022	11-08-22
Transcript : IMV Inc. - Shareholder/Analyst Call	29-06-22

IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets	04-09-23
IMV Inc. : to Present at Two Upcoming Investor Conferences	13-06-19
Imv : De nouveaux résultats sur la combinaison de DPX-Survivac d’IMV et de Keytruda® de Merck continue de montrer des bénéfices pour le traitement du lymphome diffus à grandes cellules B (LDGCB)	12-06-19
Imv : New Phase 2 Clinical Trial Results Continue to Demonstrate Potential Clinical Benefit of IMV’s DPX-Survivac in Combination with Merck’s Keytruda in Patients with DLBCL	12-06-19

Managers	Titel	Leeftijd	Van
Andrew Hall CEO	Chief Executive Officer	-	10-11-20
Brittany Davison DFI	Director of Finance/CFO	-	-
Jennifer Schmitke COO	Chief Operating Officer	-	-

Besturend	Titel	Leeftijd	Van
Michael P. Bailey CHM	Chairman	58	01-07-20
Kyle Kuvalanka BRD	Director/Board Member	56	01-04-21
Markus Warmuth BRD	Director/Board Member	53	06-11-18

IMV Inc. is een in Canada gevestigd bedrijf. Het bedrijf heeft geen bedrijfsactiviteiten.

Sector

	Vaira. 1 jan.	Kapi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+30,51%	3,64 mld.
SCREAMING EAGLE ACQUISITION CORP.	+1,51%	1,01 mld.
CHURCHILL CAPITAL CORP VII	+2,10%	982 mln.
APPLE ISPORTS GROUP, INC.	+41,91%	872 mln.
PERELLA WEINBERG PARTNERS	+23,88%	807 mln.
ARES ACQUISITION CORPORATION II	+1,53%	663 mln.
E7 GROUP	+2,33%	626 mln.
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600 mln.
ALTC ACQUISITION CORP.	+20,45%	539 mln.